What Researchers Did
Researchers studied 34 patients with severe chronic ulcerohemorrhagic colitis, treating them with 10-12 sessions of hyperbaric oxygen therapy for 60-75 minutes each, alongside their usual medical care.
What They Found
All 34 patients in the study experienced significant improvement in their condition after receiving just 5-6 hyperbaric oxygen therapy sessions. The study concluded that hyperbaric oxygenation is a beneficial addition to the treatment of chronic ulcerohemorrhagic colitis.
What This Means for Canadian Patients
For Canadian patients suffering from chronic ulcerohemorrhagic colitis, this study suggests that hyperbaric oxygen therapy could potentially offer significant relief from symptoms. While not currently a standard treatment for this condition in Canada, these findings indicate a possible complementary therapy that could improve patient outcomes.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A significant limitation of this study is the absence of a control group, which makes it difficult to definitively attribute improvements solely to hyperbaric oxygen therapy.